SenzaGen has today published its Annual Report 2020. A digital copy can be downloaded at www.senzagen.com or read via the link below.

The printed version of the annual report will be available in April. To request a printed copy, please email name and address to IR@senzagen.com.

2020 in short
In 2020, SenzaGen’s efforts to create a commercial enterprise proved effective. Because of the organizational changes we made and the sales focus we established, we tripled our sales from the previous year.

Strong belief in the future
SenzaGen’s plans for 2021 are based on continuing to strengthen our market presence and develop our organization in line with our six strategic initiatives updated for the year. We will work toward our profitability target by approaching customers and industries that stand to benefit from the GARD® test’s high predictivity without requiring OECD validation and are interested in the additional skin toxicology services that we will be able to offer through our GLP-certified lab.

Contacts

Axel Sjöblad, CEO, SenzaGen AB
Email: axel.sjoblad@senzagen.com| Mobile: +46 705-35 93 51

Tina Dackemark Lawesson, VP Marketing & Communications
Email: tina.lawesson@senzagen.com| Mobile: +46 708-20 29 44

About us

SenzaGen is a Swedish biotech company that provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. The GARD® test method combines genomic data from human cells with machine learning for a unique capability to identify and analyze whether a chemical could cause allergic reactions on the skin or in the respiratory tract. With excellent predictivity, GARD® meets needs in several industries and helps companies develop, produce and deliver safer, ethical and more sustainable products. GARD® tests are performed in SenzaGen’s GLP-approved lab and by select partners in Europe and the US. SenzaGen has its headquarters in Lund, Sweden and a subsidiary in the US. For more information, please visit: www.senzagen.com.

SenzaGen is listed on Nasdaq Stockholm First North (ticker: SENZA), and FNCA Sweden AB, +46(0)8-528 00 399, info@fnca.se, is the company’s Certified Adviser. 

Attachments

SenzaGen's Annual Report 2020

© Modular Finance, source Nordic Press Releases